Sirt1 and nuclear factor-E2 related factor 2 (Nrf2)-anti-oxidant response element (ARE) anti-oxidative pathway play important regulatory roles in the pathological progression of diabetic nephropathy (DN) induced by advanced glycation-end products (AGEs). Polydatin (PD), a glucoside of resveratrol, has been shown to possess strong anti-oxidative bioactivity. Our previous study demonstrated that PD markedly resists the progression of diabetic renal fibrosis and thus, inhibits the development of DN. Whereas, whether PD could resist DN through regulating Sirt1 and consequently promoting Nrf2-ARE pathway needs further investigation. Here, we found that concomitant with decreasing RAGE (the specific receptor for AGEs) expression, PD significantly reversed the downregulation of Sirt1 in terms of protein expression and deacetylase activity and attenuated FN and TGF- beta 1 expression in GMCs exposed to AGEs. Under AGEs-treatment condition, PD could decrease Keap1 expression and promote the nuclear content, ARE-binding ability, and transcriptional activity of Nrf2. In addition, PD increased the protein levels of heme oxygenase 1 (HO-1) and superoxide dismutase 1 (SOD1), two target genes of Nrf2. The activation of Nrf2-ARE pathway by PD eventually led to the quenching of ROS overproduction sharply boosted by AGEs. Depletion of Sirt1 blocked Nrf2-ARE pathway activation and reversed FN and TGF- beta 1 downregulation induced by PD in GMCs challenged with AGEs. Along with reducing HO-1 and SOD1 expression, silencing of Nrf2 increased FN and TGF- beta 1 levels. PD treatment elevated Sirt1 and Nrf2 levels in the kidney tissues of diabetic rats, then improved the anti-oxidative capacity and renal dysfunction of diabetic models, and finally reversed the upregulation of FN and TGF- beta 1. Taken together, the resistance of PD on upregulated FN and TGF- beta 1 induced by AGEs via oxidative stress in GMCs is closely associated with its activation of Sirt1-Nrf2-ARE pathway. Abbreviations * AGEs, advanced glycation-end products * ARE, anti-oxidant response element * BSA, bovine serum albumin * DN, diabetic nephropathy * ECM, extracellular matrix * EMSA, electrophoretic mobility shift assay * FN, fibronectin * GMCs, glomerular mesangial cells * HG, high glucose * HO-1, heme oxygenase 1 * Keap1, kelch like ECH-associated protein 1 * SOD, superoxide dismutase * MDA, malondialdehyde * NAD super(+), nicotinamide adenosine dinucleotide super(+) * Nrf2, nuclear factor E2-related factor 2 * OSS, oxidative stress * PD, polydatin * RAGE, the specific receptor for AGEs * ROS, reactive oxygen species * STZ, streptozocin * TGF- beta 1, transforming growth factor- beta 1